Auriga maintains a 'Hold' on athenahealth (ATHN); Vulnerable in a Volatile Market at Current Valuation
Get Alerts ATHN Hot Sheet
Price: $9.59 --0%
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
6 Buy, 22 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Auriga maintains a 'Hold' on athenahealth (NASDAQ: ATHN) price target of $53.00.
Auriga analyst says, "We find shares of athenahealth expensive (trading 6% above our $53 target) particularly in light of a precarious market environment. Shares have held up well the latest quarter despite under-performance by the health IT group and broader cloud-based computing companies. We think the near-term drag from a sequentially down Q3 (as per our and consensus estimates) in addition to long-term headwinds from health reform could put pressure on shares."
For more ratings news on athenahealth click here and for the rating history of athenahealth click here.
Shares of athenahealth closed at $56.25 yesterday.
Auriga analyst says, "We find shares of athenahealth expensive (trading 6% above our $53 target) particularly in light of a precarious market environment. Shares have held up well the latest quarter despite under-performance by the health IT group and broader cloud-based computing companies. We think the near-term drag from a sequentially down Q3 (as per our and consensus estimates) in addition to long-term headwinds from health reform could put pressure on shares."
For more ratings news on athenahealth click here and for the rating history of athenahealth click here.
Shares of athenahealth closed at $56.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fiserv (FISV) PT Lowered to $60 at Freedom Broker
- Freedom Broker Upgrades Lifeway Foods (LWAY) to Buy
- Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
AurigaSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share